Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

High affinity specific (/sup 3/H)(/sup +/)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart

Journal Article · · Life Sci.; (United States)

The binding properties of the 1,4-dihydropyridine calcium channel antagonist, (/sup 3/H)(/sup +/)PN 200-110, were studied in rat cerebral cortical and cardiac homogenates (37/sup 0/C, Krebs phosphate buffer). Specific binding of (/sup 3/H)(/sup +/)PN 200-110 was saturable, reversible, and of high affinity (K/sub d/ values are 35 and 64 pM for the cerebral cortex and heart, respectively). In parallel studies with (/sup 3/H)(/sup +/)PN 200-110, the dissocation constant of (/sup 3/H)nitrendipine was 10-12 times higher. Substituted dihydropyridine calcium channel antagonists and agonists competively inhibited specific (/sup 3/H)(/sup +/)PN 200-110 binding, but d-cis diltiazem enhanced and verapamil incompletely inhibited (/sup 3/H)(/sup +/)PN 200-110 binding in both the cerebral cortex and the heart. The effects of diltiazem and verapamil on

Research Organization:
Univ. of Arizona Coll. of Medicine, Tucson
OSTI ID:
6271877
Journal Information:
Life Sci.; (United States), Journal Name: Life Sci.; (United States) Vol. 35:7; ISSN LIFSA
Country of Publication:
United States
Language:
English

Similar Records

High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers
Journal Article · Thu May 01 00:00:00 EDT 1986 · Proc. Natl. Acad. Sci. U.S.A.; (United States) · OSTI ID:5578929

Temperature-dependent modulation of (/sup 3/H)nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes
Journal Article · Tue May 01 00:00:00 EDT 1984 · J. Pharmacol. Exp. Ther.; (United States) · OSTI ID:7017071

Potent enhancement of (/sup 3/H)nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A
Journal Article · Sat Jun 01 00:00:00 EDT 1985 · J. Pharmacol. Exp. Ther.; (United States) · OSTI ID:5253960